Roger Crystal, MD

Dr. Crystal brings more than 20 years of experience as a healthcare business executive and clinician. Until its recent acquisition by Indivior PLC, Dr. Crystal was President, Chief Executive Officer and Director for Opiant Pharmaceuticals, which was listed on NASDAQ. Dr. Crystal is the lead inventor of the NARCAN® Nasal Spray. He is named on several issued patents around this product and led its development towards FDA approval. Dr. Crystal previously served as the Chief Business Officer for ImaginAb, a venture capital-backed biotechnology company, leading the company’s efforts in immuno-oncology and managing its pharmaceutical company partnerships and licensing deals. He began his business career with roles at Goldman Sachs, A.T. Kearney, and GE Healthcare. He holds a BMedSci in Physiology and an MD from the University of Birmingham, UK and an MBA from the London Business School. Prior to his business career, Dr. Crystal worked for several years as a surgeon, specializing in ear, nose, and throat, head and neck surgery at leading institutions including Imperial College Healthcare, London and was awarded Membership of The Royal College of Surgeons of England (MRCS). He was also an Honorary Research Fellow at University College London and has authored a number of peer-reviewed scientific articles. Dr. Crystal served on the Board of Directors of the Biotechnology Innovation Organization (BIO) and is also a member of the Young Presidents’ Organization, Santa Monica Bay Chapter. He is also chairman of W12 Therapeutics and an advisor to several biopharma companies.